British Journal of Pharmacology · 2006 · 118 citations · 37 references
Life SciencesImmunologyPharmacologyCell SignalingImmunopharmacologyInflammationAnti-inflammatory PharmacologyCytokine BiologyInflammatory Cell ResponsesInflammatory MediatorsInflammatory SignalingMacrophage BiologyAnti-inflammatory ActivityAnti-inflammatory MechanismsAnti-inflammatory ResponseMacrophage Inflammatory ResponsesNuclear Factor Kappa B ActivationNuclear Factor Kappa B ModulationProinflammatory MediatorsWestern Blotting
Buddlejasaponin IV isolated from Pleurospermum kamtschatidum is an anti-inflammatory compound that inhibits NO, PGE(2) and TNF-alpha production. Here, we studied the mode of action of this compound. Buddlejasaponin IV (2.5-10 microM) reduced lipopolysaccaride (LPS (1 microg ml(-1)))-induced levels of iNOS and COX-2 at the protein levels, and iNOS, COX-2, TNF-alpha, interleukin (IL)-1beta and IL-6 mRNA expression in RAW 264.7 macrophages in a concentration-dependent manner, as determined by Western blotting and RT-PCR, respectively. Buddlejasaponin IV inhibited the LPS-induced activation of nuclear factor-kappaB (NF-kappaB), a transcription factor necessary for proinflammatory mediators, iNOS, COX-2, TNF-alpha, IL-1beta and IL-6 expression. This effect was accompanied by a parallel reduction in IkappaB-alpha degradation and phosphorylation, and by the nuclear translocation of the NF-kappaB p65 subunit. The effects of buddlejasaponin IV on acute phase inflammation were studied on serotonin- and carrageenan-induced paw edema. The antiedematous effect of buddlejasaponin IV was compared with 10 mg kg(-1) of indomethacin p.o. Maximum inhibitions of 26 and 41% were noted at a dose of 20 mg kg(-1) for serotonin- and carrageenan-induced paw edema, respectively. The analgesic effect of buddlejasaponin IV was evaluated using acetic acid-induced writhing and hot-plate tests. Buddlejasaponin IV (10 and 20 mg kg(-1), p.o.) was found to have a marked analgesic effect in both models. These results suggest that the inhibitions of the expressions of iNOS, COX-2, TNF-alpha, IL-1beta and IL-6 by blocking NF-kappaB activation, are responsible for the anti-inflammatory effects of buddlejasaponin IV isolated from P. kamtschatidum.
37
Patrick A. Baeuerle, David Baltimore · Cell · 1996 · 3K citations · Full text
Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
Keith Brown, Susan M. Gerstberger, Louise Carlson et al. · Science · 1995 · 1.4K citations
Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
Thomas Henkel, Thomas Machleidt, Irit Alkalay et al. · Nature · 1993 · 1.1K citations